Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -103.60x is 58% above its 5-year average of -249.47x, near the high end of its 5-year range (-901.81x–-25.97x).
As of the fiscal period ended Tuesday, March 31, 2026. 7.99% below its 12-month average of -95.93x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2026 (2026-03-31): -103.60x.
INTEREST COVERAGE RATIO
-103.60x
INTEREST COVERAGE RATIO AVG TTM
-95.93x
INTEREST COVERAGE RATIO AVG 3Y
-232.35x
INTEREST COVERAGE RATIO AVG 5Y
-249.47x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-7.99%
CURRENT VS 3Y AVG
+55.41%
CURRENT VS 5Y AVG
+58.47%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-1508.70%
vs the sector median at left
Virax Biolabs Group Limited
Market Cap
$378849.00
Interest Coverage Ratio
-103.60x
TTM Avg
-95.93x
3Y Avg
-232.35x
5Y Avg
-249.47x
Market Cap
$403887.00
Interest Coverage Ratio
-18.99x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$481786.00
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$250443.00
Interest Coverage Ratio
-795.36x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$518606.00
Interest Coverage Ratio
-935.33x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$545796.00
Interest Coverage Ratio
-9.00x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$110112.00
Interest Coverage Ratio
894.77x
TTM Avg
894.77x
3Y Avg
894.77x
5Y Avg
894.77x
Market Cap
$95475.00
Interest Coverage Ratio
-655.06x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$667469.00
Interest Coverage Ratio
-113.13x
TTM Avg
1218.67x
3Y Avg
620.28x
5Y Avg
620.28x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Virax Biolabs Group Limited (VRAX) | $378849.00 | -103.60x | -95.93x | -232.35x | -249.47x |
| Niki BioSolutions, Inc. (NIKI)vs › | $403887.00 | -18.99x | N/A | N/A | N/A |
| XORTX Therapeutics Inc. (XRTX)vs › | $481786.00 | N/A | N/A | N/A | N/A |
| SciSparc Ltd. (SPRC)vs › | $250443.00 | -795.36x | N/A | N/A | N/A |
| VivoSim Labs, Inc. (VIVS)vs › | $518606.00 | -935.33x | N/A | N/A | N/A |
| HCW Biologics Inc. (HCWB)vs › | $545796.00 | -9.00x | N/A | N/A | N/A |
| Silexion Therapeutics Ltd. (SLXN)vs › | $110112.00 | 894.77x | 894.77x | 894.77x | 894.77x |
| Psyence Biomedical Ltd. (PBM)vs › | $95475.00 | -655.06x | N/A | N/A | N/A |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $667469.00 | -113.13x | 1218.67x | 620.28x | 620.28x |
| PRF Technologies Ltd. (PRFX)vs › | $70884.00 | -498.70x | N/A | N/A | N/A |
Interest Coverage
-103.6x
Debt/Equity
0.05
Current Ratio
9.97
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | -103.60x |
| 2025-09-30 | -83.43x |
| 2025-03-31 | -100.77x |
| 2024-09-30 | -112.50x |
| 2024-03-31 | -226.09x |
| 2023-09-30 | -267.57x |
| 2023-03-31 | -732.46x |
| 2022-09-30 | -149.94x |
| 2022-03-31 | -901.81x |
| 2021-09-30 | -40.07x |
| 2021-03-31 | -25.97x |
| 2020-09-30 | -20.49x |
| 2020-03-31 | -7.18x |
| 2019-09-30 | -7.18x |
